Clinical Trial Details
— Status: Completed
Administrative data
NCT number |
NCT05552417 |
Other study ID # |
N-92-2022 |
Secondary ID |
|
Status |
Completed |
Phase |
N/A
|
First received |
|
Last updated |
|
Start date |
March 1, 2023 |
Est. completion date |
March 1, 2024 |
Study information
Verified date |
May 2024 |
Source |
Kasr El Aini Hospital |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
This randomized, controlled study is designed to assess the quality of analgesia provided by
ultrasound-guided bilateral pectointercostal facial block in children undergoing cardiac
surgery via midline sternotomy.
Description:
Following approval from the research and ethics committee ,preoprrative preparation, and
induction of anesthesia The patient will be assigned to two equal groups. Conventional
control group(C) (n=30) where --- children will not receive any intervention.
Pectointercostal facial group (PI) (n=30) where --children will have bilateral
Pectointercostal Block.
Patient positioning and preparation for Ultrasound-guided PIFB After skin disinfection, the
PIFB will be performed in a supine position using a high-frequency (6-13 MHz) linear
ultrasound probe (S-NerveTM; SonoSite Inc., Bothell, WA, USA). The probe will be placed at 2
cm lateral from the sternum and parallel to the sternum and will be scanned laterally to
identify 4th and 5th costal cartilage The pecto-intercostal fascial plane will be located
between the pectoralis major muscle and the external intercostal muscle or the costal
cartilage. A 22G, 50 mm peripheral block needle, Stimuplex® Ultra 360 (B. Braun, Melsungen,
Germany) will be placed under the pectoralis major and above the external intercostal muscle
with an in-plane approach with the ultrasound probe, in a caudal-to-cranial direction until
the tip is positioned in the interfascial plane between the PMM and IIM .
A test bolus of saline (1 mL) will be injected to determine that the tip has been placed in
the correct fascial layers. Finally, 1.5 mg/kg of 0.2% bupivacaine will be injected into this
plane in two locations, over the 2nd and 4th rib. The method on the other side of the PIFB
will be the same Care will be taken not to cross the toxic dose of bupivacaine (3 mg/kg). (6)
.
Heart rate, mean arterial pressure, and oxygen saturation will be monitored continuously.
After completion of the surgery, inhalational anesthetics will be stopped as well as the
muscle relaxant.
The patient will be then transferred to the ICU.Postoperative assessment and analgesic
regimen: An IV Paracetamol 15 mg / kg will be given and will be repeated every 8 hours .The
Face, Legs, Activity, Cry, Consolability scale (FLACC) (table 1) will be assessed in the PICU
and every 4 hours for 24 hours. The time to the first request of rescue postoperative
analgesic will be: "the time interval between the onset of block and the first request to
postoperative analgesia". When patients first complain of pain (FLACC score ≥4) rescue
analgesia will be given in the form of incremental intravenous morphine